Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Transplantation

• Publication date

  1994-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199404150-00009PMID 8165699PMCID PMC3022505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biliary Interleukin 6 Levels as Indicators of Hepatic Allograft Rejection in Rats

  1992cited by this paper
• Biliary interleukin 6 levels as indicators of hepatic allograft rejection in rats.

  1992cited by this paper
• Intraoperative estimation of endotoxin, TNF alpha, and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection.

  1991cited by this paper
• Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer.

  1991cited by this paper
• Soluble interleukin-2 receptor in liver transplant recipients.

  1991cited by this paper
• Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.

  1991cited by this paper
• The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.

  1991cited by this paper
• Kinetics of interleukin 6 during OKT3 treatment in renal allograft recipients.

  1990cited by this paper
• Excessive in vitro bacterial lipopolysaccharide‐induced production of monokines in cirrhosis

  1990cited by this paper
• Interleukin-6 and the acute phase response.

  1990cited by this paper
• The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation.

  1990cited by this paper
• Interleukin 6 in Infection and Cancer

  1990cited by this paper
• Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein.

  1990cited by this paper
• The acute phase response of the liver in inflammation.

  1990cited by this paper
• Interleukin-6: an overview.

  1990cited by this paper
• Soluble interleukin-2 receptor level as an indicator of liver allograft rejection.

  1989cited by this paper
• The biology of interleukin-6.

  1989cited by this paper
• Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation.

  1989cited by this paper
• EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITRO: I. Inhibition of Expression of Alloanticen‐Activated Suppressor Cells, As Well As Induction of Alloreactivity

  1989cited by this paper
• Endotoxemia and human liver transplantation.

  1989cited by this paper
• Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2.

  1989cited by this paper
• Interleukin-6 immunoreactivity in human tumors.

  1989cited by this paper
• Soluble interleukin-2 receptors in serum and bile of liver transplant recipients.

  1989cited by this paper
• High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

  1989cited by this paper
• RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN‐2, AND GAMMA‐INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS

  1989cited by this paper
• Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.

  1988cited by this paper
• Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure.

  1988cited by this paper
• Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat.

  1988cited by this paper
• Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat.

  1988cited by this paper
• Corticotropin-releasing activity of monokines.

  1985cited by this paper

• Development of a bio-inspired phagocytic stable nanoghost with anti-inflammatory properties for management of inflammation in ulcerative colitis

  2025cites this paper
• Polymorphisms in rs2069845 are associated with IL-6 and soluble IL-6 receptor levels during total joint replacement

  2024cites this paper
• Antibody‐mediated rejection in xenotransplantation: Can it be prevented or reversed?

  2023cites this paper
• Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

  2023cites this paper
• Diagnosing Acute Cellular Rejection after Paediatric Liver Transplantation—Is There Room for Interleukin Profiles?

  2023influential citation
• Sensing Acute Cellular Rejection in Liver Transplant Patients Using Liver-Derived Extracellular Particles: A Prospective, Observational Study

  2021cites this paper
• IL-6 Directed Therapy in Transplantation

  2021cites this paper
• The Scaffold Derived from GGTA1 and CMAH Gene Knockout Pigs Generated by Gene Editing Provoked Little Inflammatory Responses in a Humanized Pig Model

  2020cites this paper
• Scaffold derived from GGTA1 and CMAH double knockout pigs elicits only slight inflammation in a gene-edited pig model

  2020cites this paper
• The potential of glycomics as prognostic biomarkers in liver disease and liver transplantation.

  2019cites this paper
• USEFULNESS OF CD44 LEVEL AS A BIOMARKER IN DIAGNOSIS OF ACUTE LIVER REJECTION

  2019cites this paper
• Non invasive diagnosis of acute cellular rejection after liver transplantation - Current opinion.

  2018cites this paper
• The effect of remote ischaemic preconditioning on CD4 T cells following hepatic ischaemia reperfusion injury

  2018cites this paper
• Aus der Chirurgischen Klinik Campus Charité Mitte | Campus Virchow-Klinikum der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION

  2018influential citation
• Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation

  2018cites this paper
• The impact of serum cytokines in the development of early allograft dysfunction in living donor liver transplantation

  2018cites this paper
• Interleukin 6 at reperfusion: A potent predictor of hepatic and extrahepatic early complications after liver transplantation

  2018cites this paper
• Immunological Biomarkers in Liver Transplantation

  2015cites this paper
• CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation

  2015cites this paper
• Markers of acute rejection and graft acceptance in liver transplantation.

  2015cites this paper
• Monitoring of liver grafts with microdialysis catheters

  2013cites this paper
• Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review

  2013cites this paper
• Predicting acute cellular rejection after liver transplantation: form liver function test to immune monitoring

  2013cites this paper
• Inflammatory markers sampled by microdialysis catheters distinguish rejection from ischemia in liver grafts

  2012cites this paper
• Serum C‐reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma

  2012cites this paper
• Novel experimental therapies for intestinal ischaemia and reperfusion injury

  2011cites this paper
• Th17 promotes acute rejection following liver transplantation in rats

  2010cites this paper
• Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation

  2010cites this paper
• Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors

  2009cites this paper
• Alveolar bone loss in liver transplantation patients: relationship with prolonged steroid treatment and parathyroid hormone levels.

  2007cites this paper
• The role of cytokines in pharmacological modulation of hepatic ischemia/reperfusion injury.

  2006cites this paper
• Effect of proinflammatory cytokines (IL-6, TNF-alpha, IL-1beta) on hemodynamic performance during orthotopic liver transplantation.

  2003cites this paper
• Effect of proinflammatory cytokines (IL-6, TNF-α, IL-1β) on hemodynamic performance during orthotopic liver transplantation

  2003cites this paper
• Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns

  2003cites this paper
• Periodontal changes in liver cirrhosis and post-transplantation patients. II: radiographic findings:.

  2002cites this paper
• Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients

  2002cites this paper
• Cytokine gene polymorphisms and acute human liver graft rejection

  2002cites this paper
• Interleukin-6 in islet xenograft rejection

  2001cites this paper
• Interleukin‐6 in islet xenograft rejection

  2001cites this paper
• Factors predicting perioperative cytokine response in patients undergoing liver transplantation

  2000cites this paper
• The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man

  2000cites this paper
• Energy storage and cytokine response in patients undergoing liver transplantation.

  1999cites this paper
• Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation.

  1999cites this paper
• Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR.

  1998cites this paper
• Studies of portal hemodynamics and hepatic oxygen consumption during acute liver allograft rejection.

  1997cites this paper
• Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function.

  1997cites this paper
• Presence of anti-FKBP12 autoantibodies in patients with liver allografts: its association with allograft rejection.

  1997cites this paper
• Interleukin‐6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent

  1997cites this paper
• The Liver: New Functional, Prognostic and Diagnostic Tests

  1997cites this paper
• Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.

  1997cites this paper
• Serum interleukin-6 level after cardiac xenotransplantation in primates.

  1997cites this paper
• Differentialdiagnostik der akuten Abstoßungsreaktion und Infektion mittels Procalcitonin und Zytokinen

  1997cites this paper
• Differentialdiagnostik der akuten AbstoBungsreaktion und Infektion mittels Procalcitonin und Zytokinen Differential diagnostic of acute rejection and infection with procalcitonin and cytokines

  1997cites this paper
• Systemic liberation of interleukin‐ 1β and interleukin‐1 receptor antagonist in the perioperative phase of liver transplantation

  1996cites this paper
• Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.

  1996cites this paper
• Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.

  1996cites this paper
• Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

  1996cites this paper
• Systemic liberation of interleukin-1β and interleukin-1 receptor antagonist in the perioperative phase of liver transplantation

  1996cites this paper
• Plasmapheresis in primary dysfunction of hepatic transplants

  1996cites this paper
• Serum cytokines in human heart transplant recipients. Is there a relationship to rejection?

  1996cites this paper
• Evaluation of serum IL-8 concentrations after orthotopic liver transplantation in rats.

  1995cites this paper
• [Diagnostic value of cytokine determination in serum and plasma].

  1995cites this paper
• An Invited Review

  1995cites this paper
• Cytokines in Clinical and Experimental Transplantation

  1994cites this paper